186 related articles for article (PubMed ID: 20232543)
1. [Immunosuppressive therapy and tuberculosis].
Yoshikawa K; Yano S
Kekkaku; 2010 Jan; 85(1):33-45. PubMed ID: 20232543
[No Abstract] [Full Text] [Related]
2. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
Tomono K; Hashimoto S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
[No Abstract] [Full Text] [Related]
3. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
Asano Y; Kano Y; Shiohara T
Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
[No Abstract] [Full Text] [Related]
4. [Chemoprophylaxis for tuberculosis].
Yamagishi F
Kekkaku; 2005 Oct; 80(10):647-53. PubMed ID: 16296393
[TBL] [Abstract][Full Text] [Related]
5. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
[TBL] [Abstract][Full Text] [Related]
6. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
7. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
Taniguchi H; Izumi S
Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
[TBL] [Abstract][Full Text] [Related]
8. Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid.
Parra Ruiz J; Ortego Centeno N; Raya Alvarez E
J Rheumatol; 2003 Jul; 30(7):1657-8. PubMed ID: 12858475
[No Abstract] [Full Text] [Related]
9. Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.
Denis B; Lefort A; Flipo RM; Tubach F; Lemann M; Ravaud P; Salmon D; Mariette X; Lortholary O;
Clin Microbiol Infect; 2008 Feb; 14(2):183-6. PubMed ID: 18076664
[TBL] [Abstract][Full Text] [Related]
10. Infectious complications of biologic agents.
Martin-Mola E; Balsa A
Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis associated with anti-TNF therapy].
Takeno M; Murakami S; Ishigatsubo Y
Nihon Rinsho; 2007 Jul; 65(7):1308-13. PubMed ID: 17642248
[TBL] [Abstract][Full Text] [Related]
12. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
Matulis G; Jüni P; Villiger PM; Gadola SD
Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
[TBL] [Abstract][Full Text] [Related]
13. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
[TBL] [Abstract][Full Text] [Related]
15. Interstitial pneumonitis associated with infliximab therapy.
Villeneuve E; St-Pierre A; Haraoui B
J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
[TBL] [Abstract][Full Text] [Related]
16. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
Danko JR; Gilliland WR; Miller RS; Decker CF
Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
[TBL] [Abstract][Full Text] [Related]
18. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.
Bieber J; Kavanaugh A
Rheum Dis Clin North Am; 2004 May; 30(2):257-70, v. PubMed ID: 15172039
[TBL] [Abstract][Full Text] [Related]
19. Indeterminate results on the interferon-gamma release assay for tuberculosis screening should not be ignored.
Oon HH; Chong WS; Liew CF
Br J Dermatol; 2008 Sep; 159(4):992-3. PubMed ID: 18717676
[No Abstract] [Full Text] [Related]
20. Cryptococcal meningitis in a patient treated with infliximab.
Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
